Key Takeaways
- British legislators have designated the UK’s dependence on Palantir as an “unacceptable point of weakness” in a newly released parliamentary report
- Lawmakers identified the company’s £330 million ($444 million) NHS data platform agreement as posing vendor lock-in dangers
- The report referenced co-founder Peter Thiel’s political connections and the firm’s US defense contracts as fundamentally inconsistent with British principles
- Parliamentarians are pressing officials to activate a contract exit provision scheduled for 2027 and pursue domestic technology solutions
- Palantir’s British operations chief rejected cancellation demands, describing such actions as “frankly irresponsible”
British parliamentary officials have launched a pointed critique of Palantir’s expanding presence within the UK’s public infrastructure, expressing alarm that the nation’s reliance on the American data intelligence company creates vulnerability for confidential citizen information.
Palantir Technologies Inc., PLTR
The Commons Science, Innovation and Technology Committee released a comprehensive 70-page assessment on Wednesday, highlighting Palantir as a leading illustration of excessive dependence on a limited group of American technology corporations. The assessment characterized this dependency as an “unacceptable point of weakness.”
Shares of Palantir (PLTR) attracted attention following the report’s publication, as market participants monitored potential responses to mounting political challenges in a significant overseas market for the organization.
The centerpiece contract scrutinized in the assessment involves Palantir’s seven-year, £330 million arrangement with the National Health Service. Finalized in 2023, the agreement aims to consolidate healthcare information from throughout the NHS into a unified system enabling medical practitioners to reach conclusions more rapidly.
According to NHS representatives, the partnership has yielded “huge benefits for patients,” such as accelerated cancer diagnostics and the treatment of thousands of additional individuals monthly.
Legislators Push for Contract Termination Option
Notwithstanding these reported advantages, the committee has called upon government officials to exercise a termination option embedded in the agreement for 2027. The recommendation advocates for either identifying a British-based substitute or developing an internal capability.
Parliamentarians voiced multiple reservations about Palantir extending beyond technical contract elements. The assessment highlighted co-founder Peter Thiel’s political associations with Donald Trump and his previous statements criticizing public healthcare systems. The document also referenced Palantir’s provision of technology platforms to American defense and border enforcement agencies.
Committee members concluded this constituted a “clear mismatch with UK values” and cautioned that Britain’s digital modernization objectives might be “derailed at any time by a decision taken outside our shores.”
Committee leader Dame Chi Onwurah stated the United Kingdom faces “serious exposure” and advocated for technological independence in essential public service domains.
Company Defends Partnership
Louis Mosley, Palantir’s chief executive for British operations, responded swiftly to the committee’s findings. In a BBC radio interview, he noted the committee itself had recognized the NHS partnership was producing tangible outcomes, rendering termination calls “frankly irresponsible.”
Mosley further emphasized that Palantir secured the contract following a thoroughly transparent and competitive bidding procedure, and that NHS information remains exclusively under healthcare authority management.
Foxglove, a British advocacy organization conducting an ongoing opposition campaign targeting Palantir’s NHS participation, endorsed the parliamentary assessment. The group urged complete contract termination.
The committee’s report additionally delivered broader criticism of governmental digital planning, characterizing the administration’s £45 billion annual savings projection through digital transformation as “worryingly optimistic.”
Legislators suggested designating a cabinet-level minister exclusively responsible for overseeing the digital transformation initiative.
The UK government’s health department had not issued a statement in response to media inquiries at press time.
